APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gliclazide Sustained-release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gliclazide Sustained-release Tablet Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchGliclazide Sustained-release Tablet Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Gliclazide Sustained-release Tablet Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Gliclazide Sustained-release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gliclazide Sustained-release Tablet Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Gliclazide Sustained-release Tablet Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gliclazide Sustained-release Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gliclazide Sustained-release Tablet is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gliclazide Sustained-release Tablet include Yiling Pharmaceutical, Teva, Shijiazhuang SIYAO, Sanofi S.A., Mylan Pharmaceuticals, Lukang Jituan Saite Yaoye, Zydus Cadila Healthcare, Torrent Pharmaceuticals and Servier Laboratories, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gliclazide Sustained-release Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gliclazide Sustained-release Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Gliclazide Sustained-release Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gliclazide Sustained-release Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gliclazide Sustained-release Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gliclazide Sustained-release Tablet sales, projected growth trends, production technology, application and end-user industry.

Gliclazide Sustained-release Tablet Segment by Company

Yiling Pharmaceutical

Teva

Shijiazhuang SIYAO

Sanofi S.A.

Mylan Pharmaceuticals

Lukang Jituan Saite Yaoye

Zydus Cadila Healthcare

Torrent Pharmaceuticals

Servier Laboratories

Aurobindo Pharma

Accord Healthcare

Gliclazide Sustained-release Tablet Segment by Type

30mg

60mg

Other

Gliclazide Sustained-release Tablet Segment by Application

Hospital

Clinic

Other

Gliclazide Sustained-release Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliclazide Sustained-release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gliclazide Sustained-release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliclazide Sustained-release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gliclazide Sustained-release Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gliclazide Sustained-release Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gliclazide Sustained-release Tablet sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gliclazide Sustained-release Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 30mg Major Manufacturers Table 3. 60mg Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Gliclazide Sustained-release Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Gliclazide Sustained-release Tablet Industry Trends Table 10. Gliclazide Sustained-release Tablet Industry Drivers Table 11. Gliclazide Sustained-release Tablet Industry Opportunities and Challenges Table 12. Gliclazide Sustained-release Tablet Industry Restraints Table 13. Global Gliclazide Sustained-release Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Gliclazide Sustained-release Tablet Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Gliclazide Sustained-release Tablet Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2021-2026) Table 17. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2027-2032) Table 18. Global Gliclazide Sustained-release Tablet Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Gliclazide Sustained-release Tablet Sales by Region (2021-2026) & (k units) Table 20. Global Gliclazide Sustained-release Tablet Sales by Region (2027-2032) & (k units) Table 21. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2021-2026) Table 22. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2027-2032) Table 23. Global Gliclazide Sustained-release Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Gliclazide Sustained-release Tablet Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2021-2026) Table 27. Global Gliclazide Sustained-release Tablet Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Gliclazide Sustained-release Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Gliclazide Sustained-release Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Gliclazide Sustained-release Tablet Manufacturers, Product Type & Application Table 31. Global Gliclazide Sustained-release Tablet Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Gliclazide Sustained-release Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Gliclazide Sustained-release Tablet Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2026) Table 38. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2027-2032) Table 39. Global Gliclazide Sustained-release Tablet Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 41. Global Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 42. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2026) Table 43. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2027-2032) Table 44. Global Gliclazide Sustained-release Tablet Price by Type (2021-2026) & (US$/unit) Table 45. Global Gliclazide Sustained-release Tablet Price by Type (2027-2032) & (US$/unit) Table 46. Global Gliclazide Sustained-release Tablet Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2026) Table 50. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2027-2032) Table 51. Global Gliclazide Sustained-release Tablet Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 53. Global Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 54. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2026) Table 55. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2027-2032) Table 56. Global Gliclazide Sustained-release Tablet Price by Application (2021-2026) & (US$/unit) Table 57. Global Gliclazide Sustained-release Tablet Price by Application (2027-2032) & (US$/unit) Table 58. Yiling Pharmaceutical Company Information Table 59. Yiling Pharmaceutical Business Overview Table 60. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio Table 62. Yiling Pharmaceutical Recent Development Table 63. Teva Company Information Table 64. Teva Business Overview Table 65. Teva Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Teva Gliclazide Sustained-release Tablet Product Portfolio Table 67. Teva Recent Development Table 68. Shijiazhuang SIYAO Company Information Table 69. Shijiazhuang SIYAO Business Overview Table 70. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio Table 72. Shijiazhuang SIYAO Recent Development Table 73. Sanofi S.A. Company Information Table 74. Sanofi S.A. Business Overview Table 75. Sanofi S.A. Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio Table 77. Sanofi S.A. Recent Development Table 78. Mylan Pharmaceuticals Company Information Table 79. Mylan Pharmaceuticals Business Overview Table 80. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio Table 82. Mylan Pharmaceuticals Recent Development Table 83. Lukang Jituan Saite Yaoye Company Information Table 84. Lukang Jituan Saite Yaoye Business Overview Table 85. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio Table 87. Lukang Jituan Saite Yaoye Recent Development Table 88. Zydus Cadila Healthcare Company Information Table 89. Zydus Cadila Healthcare Business Overview Table 90. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio Table 92. Zydus Cadila Healthcare Recent Development Table 93. Torrent Pharmaceuticals Company Information Table 94. Torrent Pharmaceuticals Business Overview Table 95. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio Table 97. Torrent Pharmaceuticals Recent Development Table 98. Servier Laboratories Company Information Table 99. Servier Laboratories Business Overview Table 100. Servier Laboratories Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio Table 102. Servier Laboratories Recent Development Table 103. Aurobindo Pharma Company Information Table 104. Aurobindo Pharma Business Overview Table 105. Aurobindo Pharma Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio Table 107. Aurobindo Pharma Recent Development Table 108. Accord Healthcare Company Information Table 109. Accord Healthcare Business Overview Table 110. Accord Healthcare Gliclazide Sustained-release Tablet Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio Table 112. Accord Healthcare Recent Development Table 113. North America Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 114. North America Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 115. North America Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 116. North America Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 117. North America Gliclazide Sustained-release Tablet Sales Price by Type (2021-2026) & (US$/unit) Table 118. North America Gliclazide Sustained-release Tablet Sales Price by Type (2027-2032) & (US$/unit) Table 119. North America Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 120. North America Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 121. North America Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 122. North America Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 123. North America Gliclazide Sustained-release Tablet Sales Price by Application (2021-2026) & (US$/unit) Table 124. North America Gliclazide Sustained-release Tablet Sales Price by Application (2027-2032) & (US$/unit) Table 125. North America Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 127. North America Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 128. North America Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 129. North America Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 130. North America Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 131. North America Gliclazide Sustained-release Tablet Sales Price by Country (2021-2026) & (US$/unit) Table 132. North America Gliclazide Sustained-release Tablet Sales Price by Country (2027-2032) & (US$/unit) Table 133. United States Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 134. Canada Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 135. Mexico Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 136. Europe Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 137. Europe Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 138. Europe Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 139. Europe Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 140. Europe Gliclazide Sustained-release Tablet Sales Price by Type (2021-2026) & (US$/unit) Table 141. Europe Gliclazide Sustained-release Tablet Sales Price by Type (2027-2032) & (US$/unit) Table 142. Europe Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 145. Europe Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 146. Europe Gliclazide Sustained-release Tablet Sales Price by Application (2021-2026) & (US$/unit) Table 147. Europe Gliclazide Sustained-release Tablet Sales Price by Application (2027-2032) & (US$/unit) Table 148. Europe Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. Europe Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 150. Europe Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 151. Europe Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 152. Europe Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 153. Europe Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 154. Europe Gliclazide Sustained-release Tablet Sales Price by Country (2021-2026) & (US$/unit) Table 155. Europe Gliclazide Sustained-release Tablet Sales Price by Country (2027-2032) & (US$/unit) Table 156. Germany Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 157. France Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 158. U.K. Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 159. Italy Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 160. Russia Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 161. Spain Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 162. Netherlands Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 163. Switzerland Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 164. Sweden Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 165. Poland Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 166. China Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 167. China Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 168. China Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 169. China Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 170. China Gliclazide Sustained-release Tablet Sales Price by Type (2021-2026) & (US$/unit) Table 171. China Gliclazide Sustained-release Tablet Sales Price by Type (2027-2032) & (US$/unit) Table 172. China Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 173. China Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 174. China Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 175. China Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 176. China Gliclazide Sustained-release Tablet Sales Price by Application (2021-2026) & (US$/unit) Table 177. China Gliclazide Sustained-release Tablet Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 179. Asia Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 180. Asia Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 181. Asia Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 182. Asia Gliclazide Sustained-release Tablet Sales Price by Type (2021-2026) & (US$/unit) Table 183. Asia Gliclazide Sustained-release Tablet Sales Price by Type (2027-2032) & (US$/unit) Table 184. Asia Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 185. Asia Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 186. Asia Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 187. Asia Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 188. Asia Gliclazide Sustained-release Tablet Sales Price by Application (2021-2026) & (US$/unit) Table 189. Asia Gliclazide Sustained-release Tablet Sales Price by Application (2027-2032) & (US$/unit) Table 190. Asia Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. Asia Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. Asia Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. Asia Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 194. Asia Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 195. Asia Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 196. Asia Gliclazide Sustained-release Tablet Sales Price by Country (2021-2026) & (US$/unit) Table 197. Asia Gliclazide Sustained-release Tablet Sales Price by Country (2027-2032) & (US$/unit) Table 198. Japan Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 199. South Korea Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 200. India Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 201. Australia Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 202. Taiwan Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 203. Southeast Asia Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 204. SAMEA Gliclazide Sustained-release Tablet Revenue by Type (2021-2026) & (US$ Million) Table 205. SAMEA Gliclazide Sustained-release Tablet Revenue by Type (2027-2032) & (US$ Million) Table 206. SAMEA Gliclazide Sustained-release Tablet Sales by Type (2021-2026) & (k units) Table 207. SAMEA Gliclazide Sustained-release Tablet Sales by Type (2027-2032) & (k units) Table 208. SAMEA Gliclazide Sustained-release Tablet Sales Price by Type (2021-2026) & (US$/unit) Table 209. SAMEA Gliclazide Sustained-release Tablet Sales Price by Type (2027-2032) & (US$/unit) Table 210. SAMEA Gliclazide Sustained-release Tablet Revenue by Application (2021-2026) & (US$ Million) Table 211. SAMEA Gliclazide Sustained-release Tablet Revenue by Application (2027-2032) & (US$ Million) Table 212. SAMEA Gliclazide Sustained-release Tablet Sales by Application (2021-2026) & (k units) Table 213. SAMEA Gliclazide Sustained-release Tablet Sales by Application (2027-2032) & (k units) Table 214. SAMEA Gliclazide Sustained-release Tablet Sales Price by Application (2021-2026) & (US$/unit) Table 215. SAMEA Gliclazide Sustained-release Tablet Sales Price by Application (2027-2032) & (US$/unit) Table 216. SAMEA Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 217. SAMEA Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 218. SAMEA Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 219. SAMEA Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 220. SAMEA Gliclazide Sustained-release Tablet Sales by Country (2021-2026) & (k units) Table 221. SAMEA Gliclazide Sustained-release Tablet Sales by Country (2027-2032) & (k units) Table 222. SAMEA Gliclazide Sustained-release Tablet Sales Price by Country (2021-2026) & (US$/unit) Table 223. SAMEA Gliclazide Sustained-release Tablet Sales Price by Country (2027-2032) & (US$/unit) Table 224. Brazil Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 225. Argentina Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 226. Chile Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 227. Colombia Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 228. Peru Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 229. Saudi Arabia Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 230. Israel Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 231. UAE Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 232. Turkey Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 233. Iran Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 234. Egypt Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Table 235. Key Raw Materials Table 236. Raw Materials Key Suppliers Table 237. Gliclazide Sustained-release Tablet Distributors List Table 238. Gliclazide Sustained-release Tablet Customers List Table 239. Research Programs/Design for This Report Table 240. Authors List of This Report Table 241. Secondary Sources Table 242. Primary Sources List of Figures Figure 1. Gliclazide Sustained-release Tablet Image Figure 2. Global Gliclazide Sustained-release Tablet Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gliclazide Sustained-release Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 4. 30mg Image Figure 5. 60mg Image Figure 6. Other Image Figure 7. Global Gliclazide Sustained-release Tablet Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Gliclazide Sustained-release Tablet Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Gliclazide Sustained-release Tablet Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gliclazide Sustained-release Tablet Revenue (2021-2032) & (US$ Million) Figure 14. Global Gliclazide Sustained-release Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2021-2032) Figure 17. Global Gliclazide Sustained-release Tablet Sales (2021-2032) & (k units) Figure 18. Global Gliclazide Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Gliclazide Sustained-release Tablet Sales YoY (2021-2032) & (k units) Figure 21. Europe Gliclazide Sustained-release Tablet Sales YoY (2021-2032) & (k units) Figure 22. China Gliclazide Sustained-release Tablet Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Gliclazide Sustained-release Tablet Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Gliclazide Sustained-release Tablet Sales YoY (2021-2032) & (k units) Figure 25. Global Gliclazide Sustained-release Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Gliclazide Sustained-release Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Gliclazide Sustained-release Tablet Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2032) Figure 31. Global Gliclazide Sustained-release Tablet Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Gliclazide Sustained-release Tablet Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2032) Figure 34. Global Gliclazide Sustained-release Tablet Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2032) Figure 37. Global Gliclazide Sustained-release Tablet Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Gliclazide Sustained-release Tablet Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2032) Figure 40. North America Gliclazide Sustained-release Tablet Revenue Share by Type (2021-2032) Figure 41. North America Gliclazide Sustained-release Tablet Sales Share by Type (2021-2032) Figure 42. North America Gliclazide Sustained-release Tablet Revenue Share by Application (2021-2032) Figure 43. North America Gliclazide Sustained-release Tablet Sales Share by Application (2021-2032) Figure 44. North America Gliclazide Sustained-release Tablet Revenue Share by Country (2021-2032) Figure 45. North America Gliclazide Sustained-release Tablet Sales Share by Country (2021-2032) Figure 46. Europe Gliclazide Sustained-release Tablet Revenue Share by Type (2021-2032) Figure 47. Europe Gliclazide Sustained-release Tablet Sales Share by Type (2021-2032) Figure 48. Europe Gliclazide Sustained-release Tablet Revenue Share by Application (2021-2032) Figure 49. Europe Gliclazide Sustained-release Tablet Sales Share by Application (2021-2032) Figure 50. Europe Gliclazide Sustained-release Tablet Revenue Share by Country (2021-2032) Figure 51. Europe Gliclazide Sustained-release Tablet Sales Share by Country (2021-2032) Figure 52. China Gliclazide Sustained-release Tablet Revenue Share by Type (2021-2032) Figure 53. China Gliclazide Sustained-release Tablet Sales Share by Type (2021-2032) Figure 54. China Gliclazide Sustained-release Tablet Revenue Share by Application (2021-2032) Figure 55. China Gliclazide Sustained-release Tablet Sales Share by Application (2021-2032) Figure 56. Asia Gliclazide Sustained-release Tablet Revenue Share by Type (2021-2032) Figure 57. Asia Gliclazide Sustained-release Tablet Sales Share by Type (2021-2032) Figure 58. Asia Gliclazide Sustained-release Tablet Revenue Share by Application (2021-2032) Figure 59. Asia Gliclazide Sustained-release Tablet Sales Share by Application (2021-2032) Figure 60. Asia Gliclazide Sustained-release Tablet Revenue Share by Country (2021-2032) Figure 61. Asia Gliclazide Sustained-release Tablet Sales Share by Country (2021-2032) Figure 62. SAMEA Gliclazide Sustained-release Tablet Revenue Share by Type (2021-2032) Figure 63. SAMEA Gliclazide Sustained-release Tablet Sales Share by Type (2021-2032) Figure 64. SAMEA Gliclazide Sustained-release Tablet Revenue Share by Application (2021-2032) Figure 65. SAMEA Gliclazide Sustained-release Tablet Sales Share by Application (2021-2032) Figure 66. SAMEA Gliclazide Sustained-release Tablet Revenue Share by Country (2021-2032) Figure 67. SAMEA Gliclazide Sustained-release Tablet Sales Share by Country (2021-2032) Figure 68. Gliclazide Sustained-release Tablet Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Gliclazide Sustained-release Tablet Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 30mg
  • 60mg
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yiling Pharmaceutical
  • Teva
  • Shijiazhuang SIYAO
  • Sanofi S.A.
  • Mylan Pharmaceuticals
  • Lukang Jituan Saite Yaoye
  • Zydus Cadila Healthcare
  • Torrent Pharmaceuticals
  • Servier Laboratories
  • Aurobindo Pharma
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gliclazide Sustained-release Tablet Market by Type
  3. 1.2.1 Global Gliclazide Sustained-release Tablet Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 30mg
  5. 1.2.3 60mg
  6. 1.2.4 Other
  7. 1.3 Gliclazide Sustained-release Tablet Market by Application
  8. 1.3.1 Global Gliclazide Sustained-release Tablet Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Gliclazide Sustained-release Tablet Market Dynamics
  1. 2.1 Gliclazide Sustained-release Tablet Industry Trends
  2. 2.2 Gliclazide Sustained-release Tablet Industry Drivers
  3. 2.3 Gliclazide Sustained-release Tablet Industry Opportunities and Challenges
  4. 2.4 Gliclazide Sustained-release Tablet Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gliclazide Sustained-release Tablet Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gliclazide Sustained-release Tablet Revenue by Region
  3. 3.2.1 Global Gliclazide Sustained-release Tablet Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gliclazide Sustained-release Tablet Revenue by Region (2021-2026)
  5. 3.2.3 Global Gliclazide Sustained-release Tablet Revenue by Region (2027-2032)
  6. 3.2.4 Global Gliclazide Sustained-release Tablet Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gliclazide Sustained-release Tablet Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gliclazide Sustained-release Tablet Sales by Region
  9. 3.4.1 Global Gliclazide Sustained-release Tablet Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gliclazide Sustained-release Tablet Sales by Region (2021-2026)
  11. 3.4.3 Global Gliclazide Sustained-release Tablet Sales by Region (2027-2032)
  12. 3.4.4 Global Gliclazide Sustained-release Tablet Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gliclazide Sustained-release Tablet Revenue by Manufacturers
  2. 4.1.1 Global Gliclazide Sustained-release Tablet Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gliclazide Sustained-release Tablet Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gliclazide Sustained-release Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gliclazide Sustained-release Tablet Sales by Manufacturers
  6. 4.2.1 Global Gliclazide Sustained-release Tablet Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gliclazide Sustained-release Tablet Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gliclazide Sustained-release Tablet Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gliclazide Sustained-release Tablet Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gliclazide Sustained-release Tablet Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gliclazide Sustained-release Tablet Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gliclazide Sustained-release Tablet Manufacturers, Product Type & Application
  13. 4.7 Global Gliclazide Sustained-release Tablet Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gliclazide Sustained-release Tablet Market CR5 and HHI
  16. 4.8.2 2025 Gliclazide Sustained-release Tablet Tier 1, Tier 2, and Tier 3
5 Gliclazide Sustained-release Tablet Market by Type
  1. 5.1 Global Gliclazide Sustained-release Tablet Revenue by Type
  2. 5.1.1 Global Gliclazide Sustained-release Tablet Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gliclazide Sustained-release Tablet Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gliclazide Sustained-release Tablet Sales by Type
  6. 5.2.1 Global Gliclazide Sustained-release Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gliclazide Sustained-release Tablet Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gliclazide Sustained-release Tablet Price by Type
6 Gliclazide Sustained-release Tablet Market by Application
  1. 6.1 Global Gliclazide Sustained-release Tablet Revenue by Application
  2. 6.1.1 Global Gliclazide Sustained-release Tablet Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gliclazide Sustained-release Tablet Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gliclazide Sustained-release Tablet Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gliclazide Sustained-release Tablet Sales by Application
  6. 6.2.1 Global Gliclazide Sustained-release Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gliclazide Sustained-release Tablet Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Gliclazide Sustained-release Tablet Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gliclazide Sustained-release Tablet Price by Application
7 Company Profiles
  1. 7.1 Yiling Pharmaceutical
  2. 7.1.1 Yiling Pharmaceutical Company Information
  3. 7.1.2 Yiling Pharmaceutical Business Overview
  4. 7.1.3 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Yiling Pharmaceutical Gliclazide Sustained-release Tablet Product Portfolio
  6. 7.1.5 Yiling Pharmaceutical Recent Developments
  7. 7.2 Teva
  8. 7.2.1 Teva Company Information
  9. 7.2.2 Teva Business Overview
  10. 7.2.3 Teva Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Teva Gliclazide Sustained-release Tablet Product Portfolio
  12. 7.2.5 Teva Recent Developments
  13. 7.3 Shijiazhuang SIYAO
  14. 7.3.1 Shijiazhuang SIYAO Company Information
  15. 7.3.2 Shijiazhuang SIYAO Business Overview
  16. 7.3.3 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Shijiazhuang SIYAO Gliclazide Sustained-release Tablet Product Portfolio
  18. 7.3.5 Shijiazhuang SIYAO Recent Developments
  19. 7.4 Sanofi S.A.
  20. 7.4.1 Sanofi S.A. Company Information
  21. 7.4.2 Sanofi S.A. Business Overview
  22. 7.4.3 Sanofi S.A. Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Sanofi S.A. Gliclazide Sustained-release Tablet Product Portfolio
  24. 7.4.5 Sanofi S.A. Recent Developments
  25. 7.5 Mylan Pharmaceuticals
  26. 7.5.1 Mylan Pharmaceuticals Company Information
  27. 7.5.2 Mylan Pharmaceuticals Business Overview
  28. 7.5.3 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
  30. 7.5.5 Mylan Pharmaceuticals Recent Developments
  31. 7.6 Lukang Jituan Saite Yaoye
  32. 7.6.1 Lukang Jituan Saite Yaoye Company Information
  33. 7.6.2 Lukang Jituan Saite Yaoye Business Overview
  34. 7.6.3 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Lukang Jituan Saite Yaoye Gliclazide Sustained-release Tablet Product Portfolio
  36. 7.6.5 Lukang Jituan Saite Yaoye Recent Developments
  37. 7.7 Zydus Cadila Healthcare
  38. 7.7.1 Zydus Cadila Healthcare Company Information
  39. 7.7.2 Zydus Cadila Healthcare Business Overview
  40. 7.7.3 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Zydus Cadila Healthcare Gliclazide Sustained-release Tablet Product Portfolio
  42. 7.7.5 Zydus Cadila Healthcare Recent Developments
  43. 7.8 Torrent Pharmaceuticals
  44. 7.8.1 Torrent Pharmaceuticals Company Information
  45. 7.8.2 Torrent Pharmaceuticals Business Overview
  46. 7.8.3 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Torrent Pharmaceuticals Gliclazide Sustained-release Tablet Product Portfolio
  48. 7.8.5 Torrent Pharmaceuticals Recent Developments
  49. 7.9 Servier Laboratories
  50. 7.9.1 Servier Laboratories Company Information
  51. 7.9.2 Servier Laboratories Business Overview
  52. 7.9.3 Servier Laboratories Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Servier Laboratories Gliclazide Sustained-release Tablet Product Portfolio
  54. 7.9.5 Servier Laboratories Recent Developments
  55. 7.10 Aurobindo Pharma
  56. 7.10.1 Aurobindo Pharma Company Information
  57. 7.10.2 Aurobindo Pharma Business Overview
  58. 7.10.3 Aurobindo Pharma Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Aurobindo Pharma Gliclazide Sustained-release Tablet Product Portfolio
  60. 7.10.5 Aurobindo Pharma Recent Developments
  61. 7.11 Accord Healthcare
  62. 7.11.1 Accord Healthcare Company Information
  63. 7.11.2 Accord Healthcare Business Overview
  64. 7.11.3 Accord Healthcare Gliclazide Sustained-release Tablet Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Accord Healthcare Gliclazide Sustained-release Tablet Product Portfolio
  66. 7.11.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Gliclazide Sustained-release Tablet Market Size by Type
  2. 8.1.1 North America Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  3. 8.1.2 North America Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  4. 8.1.3 North America Gliclazide Sustained-release Tablet Price by Type (2021-2032)
  5. 8.2 North America Gliclazide Sustained-release Tablet Market Size by Application
  6. 8.2.1 North America Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  7. 8.2.2 North America Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 8.2.3 North America Gliclazide Sustained-release Tablet Price by Application (2021-2032)
  9. 8.3 North America Gliclazide Sustained-release Tablet Market Size by Country
  10. 8.3.1 North America Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gliclazide Sustained-release Tablet Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gliclazide Sustained-release Tablet Market Size by Type
  2. 9.1.1 Europe Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  4. 9.1.3 Europe Gliclazide Sustained-release Tablet Price by Type (2021-2032)
  5. 9.2 Europe Gliclazide Sustained-release Tablet Market Size by Application
  6. 9.2.1 Europe Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 9.2.3 Europe Gliclazide Sustained-release Tablet Price by Application (2021-2032)
  9. 9.3 Europe Gliclazide Sustained-release Tablet Market Size by Country
  10. 9.3.1 Europe Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gliclazide Sustained-release Tablet Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gliclazide Sustained-release Tablet Market Size by Type
  2. 10.1.1 China Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  3. 10.1.2 China Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  4. 10.1.3 China Gliclazide Sustained-release Tablet Price by Type (2021-2032)
  5. 10.2 China Gliclazide Sustained-release Tablet Market Size by Application
  6. 10.2.1 China Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  7. 10.2.2 China Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 10.2.3 China Gliclazide Sustained-release Tablet Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gliclazide Sustained-release Tablet Market Size by Type
  2. 11.1.1 Asia Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  4. 11.1.3 Asia Gliclazide Sustained-release Tablet Price by Type (2021-2032)
  5. 11.2 Asia Gliclazide Sustained-release Tablet Market Size by Application
  6. 11.2.1 Asia Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 11.2.3 Asia Gliclazide Sustained-release Tablet Price by Application (2021-2032)
  9. 11.3 Asia Gliclazide Sustained-release Tablet Market Size by Country
  10. 11.3.1 Asia Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gliclazide Sustained-release Tablet Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gliclazide Sustained-release Tablet Market Size by Type
  2. 12.1.1 SAMEA Gliclazide Sustained-release Tablet Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gliclazide Sustained-release Tablet Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gliclazide Sustained-release Tablet Price by Type (2021-2032)
  5. 12.2 SAMEA Gliclazide Sustained-release Tablet Market Size by Application
  6. 12.2.1 SAMEA Gliclazide Sustained-release Tablet Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gliclazide Sustained-release Tablet Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gliclazide Sustained-release Tablet Price by Application (2021-2032)
  9. 12.3 SAMEA Gliclazide Sustained-release Tablet Market Size by Country
  10. 12.3.1 SAMEA Gliclazide Sustained-release Tablet Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gliclazide Sustained-release Tablet Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gliclazide Sustained-release Tablet Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gliclazide Sustained-release Tablet Value Chain Analysis
  2. 13.1.1 Gliclazide Sustained-release Tablet Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gliclazide Sustained-release Tablet Production Mode & Process
  6. 13.2 Gliclazide Sustained-release Tablet Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gliclazide Sustained-release Tablet Distributors
  9. 13.2.3 Gliclazide Sustained-release Tablet Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst